Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia

Abstract Chronic lymphocytic leukemia (CLL) is a B lymphoid malignancy highly dependent on the microenvironment. Despite new targeted therapies such as ibrutinib and venetoclax, disease progression and relapse remain an issue. CLL cell interactions with the supportive tissue microenvironment play a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Neus Gimenez, Rupal Tripathi, Ariadna Giró, Laia Rosich, Mònica López-Guerra, Irene López-Oreja, Heribert Playa-Albinyana, Fabian Arenas, José Manuel Mas, Patricia Pérez-Galán, Julio Delgado, Elias Campo, Judith Farrés, Dolors Colomer
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/eaa533646552409fbba838dfbdc5b89d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!